4//SEC Filing
Kruse Bo 4
Accession 0001104659-21-150626
CIK 0001722964other
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 6:01 PM ET
Size
5.7 KB
Accession
0001104659-21-150626
Insider Transaction Report
Form 4
Kruse Bo
DirectorEVP, CFO, Secy & Treas.
Transactions
- Award
Employee Stock Option (right to buy)
2021-12-14+85,000→ 85,000 totalExercise: $15.73Exp: 2031-12-14→ Common stock (85,000 underlying)
Footnotes (2)
- [F1]Stock options granted to the Reporting Person pursuant to the 2018 Equity Incentive Plan of Y-mAbs Therapeutics, Inc.
- [F2]The stock option shall vest and become exercisable as to 25% of the shares subject to the option on December 15, 2022, and thereafter vests and become exercisable as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.
Documents
Issuer
Y-mAbs Therapeutics, Inc.
CIK 0001722964
Entity typeother
Related Parties
1- filerCIK 0001752940
Filing Metadata
- Form type
- 4
- Filed
- Dec 15, 7:00 PM ET
- Accepted
- Dec 16, 6:01 PM ET
- Size
- 5.7 KB